Novatrials

20/10/2026

Tired of trying to lose weight? We’re looking for adult volunteers who are overweight to participate in a weight loss clinical study. The study drug is a once-weekly injection of a potential new weight loss treatment.

The study may be suitable for you if:
• Your BMI is over 30 or
• Your BMI is over 27 and you have a weight related health condition

Study-related care and medication are provided at no cost. Participants receive reimbursement for travel to attend visits at our Charlestown clinic.

Click through to our website to find out more details. https://loom.ly/RS9IyN0

This study has been approved by Bellberry Human Research Ethics Committee.

19/10/2026

Volunteers with type 2 diabetes (T2D) wanted to participate in a study of a potential new treatment. The study will investigate a new drug that may assist people with T2D to achieve recommended blood glucose levels. https://loom.ly/CqTryEA

This study may be suitable for you if you:
• Are aged 18-75 years
• Have been diagnosed with T2D
• Are on a stable dose of T2D medication
• Have a BMI between 25 and 50

Participants receive travel reimbursement to attend visits at our Charlestown clinic. Study-related care and medication are provided at no cost.

This study has been approved by Bellberry Human Research Ethics Committee.

18/10/2026

PTSD clinical trial now enrolling! Potential new treatment for adults with PTSD.

✓ Ages 18-65
✓ Diagnosed PTSD required
✓ 3-month study at our Newcastle clinic
✓ All medical care free
✓ Time and travel reimbursement included

If current treatments aren't giving you the relief you deserve, this research study may offer a new path forward. https://loom.ly/qBulsWk

This study has been approved by Bellberry Human Research Ethics Committee.

17/10/2026

Nervous about your first visit? That's completely normal 💜 At a Novatrials screening visit, you can ask as many questions as you like, and our team will happily explain everything.

Depending on the study, you’ll receive a range of health checks to make sure the study is right for you before you make your final decision.

See what to expect: https://loom.ly/zcJDQz8

Curious about a clinical trial screening visit? Find out what happens, who you'll meet, how long it takes and what comes next at Novatrials in Charlestown.

16/10/2026

Are you overweight? We’re looking for volunteers, with or without type 2 diabetes, for a weight loss clinical study.

The study drug is a potential new oral treatment that may assist in weight loss and, for participants with type 2 diabetes, improve blood glucose levels.

You may be suitable to join this study if:
• Your BMI is over 30 or
• Your BMI is over 25 and you have a weight related health condition or
• Your BMI is over 25 and you have type 2 diabetes

Study-related care and medication are provided at no cost. Participants receive reimbursement for time and travel to attend visits at our Charlestown clinic.

Visit our website to find out more or see if you might be eligible. https://loom.ly/v92UyNs

This study has been approved by Metro South Human Research Ethics Committee.

15/10/2026

Ever wondered what it's actually like to take part in a clinical trial? Novatrials is inviting healthy volunteers aged 18–65 to join a paid medical study in Charlestown.

You’ll receive trial-related medical supervision, comfortable accommodation, and reimbursement of around $600 per night for your time. https://loom.ly/i5Bjdn4

This study has been approved by Bellberry Human Research Ethics Committee.

15/10/2026

What if a cancer treatment could be tailored to your tumour's unique genetic fingerprint? That is now closer to reality than ever. A landmark Phase 3 clinical trial involving more than 1,100 patients has found that an experimental mRNA drug can prevent melanoma from returning and stop it from spreading to other organs.

The trial was led by Professor Georgina Long from the University of Sydney and Melanoma Institute Australia, a reminder that Australian researchers continue to be at the forefront of some of the world's most significant cancer breakthroughs ☀️
Read more: https://loom.ly/mZppFww

A trial of more than 1,100 patients finds a new experimental drug could prevent one of the deadliest forms of skin cancer from returning.

13/10/2026

Tired of trying to lose weight while managing your type 2 diabetes (T2D)? We’re looking for adult volunteers to participate in a T2D weight loss clinical study. The study drug is a once-weekly injection of a potential new weight loss treatment.

The study may be suitable for you if:
• You have been diagnosed with T2D
• Your BMI is 27 or more

Study-related care and medication are provided at no cost. Participants receive reimbursement for travel to attend visits at our Charlestown clinic.

Click through to our website to find out more details. https://loom.ly/kCECkeY

This study has been approved by Bellberry Human Research Ethics Committee.

12/10/2026

Breathlessness. Persistent coughing. Flare-ups that stop you in your tracks. If you're living with moderate to severe COPD, you know how much it can take from you.

Novatrials is offering people aged 40–80 with a COPD diagnosis the opportunity to take part in a clinical study of a potential new inhaled treatment that may help improve breathing and reduce airway inflammation.

All study-related care and medication is provided at no cost, and you'll be reimbursed for your time and travel to our Charlestown clinic.

Visit the Novatrials website to find out more and check if you may be suitable. https://loom.ly/wCc8Lsg

This study has been approved by Bellberry Human Research Ethics Committee.

11/10/2026

Help advance diabetes treatment research while receiving expert care at no cost. This 28-week study involves a once-weekly injection designed to support weight loss and improve health outcomes.

Receive trial-related care at no cost, plus reimbursement for time and travel to our Charlestown clinic.

Adults 18 to 70 with type 2 diabetes and a BMI between 27 and 40 may apply. https://loom.ly/v-TyAMY

This study has been approved by Bellberry Human Research Ethics Committee.